LOGAN ROGERS: Open Payments
NPI 1710448972 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 42 payments from 10 companies in 2025. Trend: 2023 $174 · 2024 $402 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 14 | $218 |
| Otsuka America Pharmaceutical, Inc. | 10 | $144 |
| Axsome Therapeutics, Inc. | 5 | $98 |
| Corium, LLC | 5 | $78 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Alkermes, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Almatica Pharma LLC | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $15 |
Products named: Qelbree, REXULTI, Auvelity, Azstarys, FANAPT, ARISTADA, TRINTELLIX, LOREEV XR.
Industry payments across AL — which companies pay providers there.
